viaflo 5% glucose 12.5g/250ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
viaflo 5% glucose 100ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
viaflo 5% glucose 50ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
baxter 70% anhydrous glucose 350g/500ml injection bp ahb0293
baxter healthcare pty ltd - glucose, quantity: 700 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
baxter 50% anhydrous glucose 250g/500ml injection bp bag ahb0253
baxter healthcare pty ltd - glucose, quantity: 500 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
baxter 5% glucose 50ml injection bp ahb0086 ahb0093
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
baxter 10% anhydrous glucose 500ml injection ahb0163
baxter healthcare pty ltd - glucose, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
baxter 0.244% potassium chloride and 0.18% sodium chloride and 4% glucose 1000ml injection ahb1224
baxter healthcare pty ltd - glucose, quantity: 40 g/l; potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - the potassium chloride (0.224%), sodium chloride (0.18%), and glucose (4%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.
baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag
baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.
baxter 0.224% potassium chloride and 5% glucose 1000ml injection ahb1174
baxter healthcare pty ltd - glucose, quantity: 50 g/l; potassium chloride, quantity: 2.24 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the potassium chloride in glucose (5%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of potassium and chloride ion concentrations. this is also an alternative route of administration for the patients who are unable to take potassium orally or if hypokalaemia is severe. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.